NASH/MASH Treatment Market Set to Quadruple by 2033: Unveiling Future Trends and Billion-Dollar Opportunities

The Global NASH/MASH Treatment Market reached US$ 7.87 billion in 2024 and is expected to reach US$ 31.76 billion by 2033, growing at a CAGR of 17.7% during the forecast period 2025-2033. The approved drugs market value is reported at US$ 178.31 million in 2024 and is expected to reach US$ 16.82 billion in 2033 growing at a CAGR of 57.05%.

📌 Download your Exclusive Sample Report Today: (Corporate Email gets priority access):- https://www.datamintelligence.com/download-sample/nash-or-mash-treatment-market?kb

☛ Nash/Mash Treatment Market Recent Developments 2025:

United States: Recent Industry Developments

✅ In July 2025, SkyCharge Inc. launched an automated drone battery swapping station in Texas. The system enables commercial delivery drones to swap batteries in under 90 seconds, increasing operational efficiency by 40%.

✅ In June 2025, DroneX partnered with a California-based logistics company to integrate battery swapping solutions into its delivery fleet. Full deployment is expected by Q1 2026, supporting same-day deliveries.

✅ In May 2025, AeroPower introduced a modular battery swapping system for agricultural drones. The system extends flight time for crop monitoring and spraying applications, representing a $10 million investment in sustainable drone operations.

Japan: Recent Industry Developments

✅ In July 2025, NEC Aviation unveiled a rapid battery swapping hub for industrial drones in Tokyo. The hub focuses on minimizing downtime for inspection and surveillance drones in urban areas.

✅ In June 2025, Yamaha Motor developed a smart battery swapping solution for delivery drones, incorporating IoT monitoring for real-time battery health tracking. Pilot testing is underway in Osaka.

✅ In May 2025, SoftBank Robotics partnered with regional airports to deploy battery swapping stations for logistics and inspection drones. The initiative aims to enhance drone flight efficiency across Japan's airspace.

☛ Nash/Mash Treatment Market: Drivers

The NASH/MASH treatment market is gaining momentum due to the increasing prevalence of metabolic disorders such as obesity, type 2 diabetes, and dyslipidemia. Nonalcoholic steatohepatitis (NASH) and metabolic dysfunction-associated steatohepatitis (MASH) have emerged as major liver diseases linked to sedentary lifestyles and unhealthy dietary habits. Growing awareness of the long-term consequences of untreated liver inflammation, including cirrhosis and hepatocellular carcinoma, is driving demand for effective therapeutics. Pharmaceutical companies are accelerating R&D to develop novel drugs targeting fibrosis, inflammation, and lipid metabolism. Rising healthcare spending and improved diagnostic capabilities are further supporting the adoption of early treatment options.

Advancements in biomarker research and imaging technologies are enhancing early detection and clinical management of NASH/MASH, contributing to the expansion of the treatment landscape. The introduction of non-invasive diagnostic tools is enabling more patients to access care without liver biopsy procedures, boosting treatment uptake. Strategic collaborations between biotech firms and research institutions are expediting clinical trials for promising drug candidates. Additionally, government initiatives to address the rising burden of chronic liver diseases are fostering a favorable regulatory environment. With increasing patient awareness and pipeline innovation, the NASH/MASH treatment market is poised for significant growth in the coming years.

📌 Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/nash-or-mash-treatment-market?kb

☛ Nash/Mash Treatment Market: Major Players

Novo Nordisk A/S, Boehringer Ingelheim International GmbH., 89bio, Inc., Inventiva., CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD, Sagimet Biosciences., and Akero Therapeutics, Inc.

Research Methodology

We follow a hybrid research approach, combining qualitative insights with rigorous quantitative analysis to deliver reliable and comprehensive market intelligence. Our process begins with extensive secondary research, drawing on trusted industry reports, proprietary databases, and credible market sources. This is then reinforced through targeted primary research, including structured surveys and in-depth interviews with industry leaders, subject matter experts, and key market participants.

☛ Segments Covered in the Nash/Mash Treatment Market:

By Drug: Resmetirom (Rezdiffra) | Lanifibranor | Semaglutide | Survodutide | Pegozafermin | Efruxifermin | Denifanstat | Others

By Stage: Stage 0-1 | Stage 2-3 | Stage 4

By Age Group: Pediatrics | Adults | Geriatrics

By Gender: Male | Female

📌 Get Corporate Access to Live Nash/Mash Treatment Industry Intelligence Database: https://www.datamintelligence.com/buy-now-page?report=nash-or-mash-treatment-market?kb

☛ Regional Analysis for Nash/Mash Treatment Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

📌 Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription

☛ Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

☛ Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.